NCT02613039View on ClinicalTrials.gov

Oral Contraceptive Therapy and Sexuality

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2019

Conditions
Contraceptive UsageSexual BehaviorMental Health Wellness 1
Interventions
DRUG

Combined Estrogen-Progestin Oral Contraceptives

All patients enrolled will undergo Combined Estrogen-Progestin Oral Contraceptives. Different compounds will be chosen according to the approved indications and clinical practice. Therefore it is not possible to provide a specific trade and/or generic name.

Trial Locations (1)

Unknown

Ambulatori di Medicina della Sessualità e Andrologia, Florence

All Listed Sponsors
lead

University of Florence

OTHER

NCT02613039 - Oral Contraceptive Therapy and Sexuality | Biotech Hunter | Biotech Hunter